These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 151872)

  • 21. [Neurologic indications for bromocriptine (in addition to Parkinson's disease)].
    Destee A
    LARC Med; 1984 Feb; 4(2):107-11. PubMed ID: 6232436
    [No Abstract]   [Full Text] [Related]  

  • 22. Use of choline and lecithin in the treatment of tardive dyskinesia.
    Zeisel SH; Gelenberg AJ; Growdon JH; Wurtman RJ
    Adv Biochem Psychopharmacol; 1980; 24():463-70. PubMed ID: 6996444
    [No Abstract]   [Full Text] [Related]  

  • 23. Drug holiday in Huntington's disease.
    Schmidt EZ; Hofmann P; Kapfhammer HP; Bonelli RM
    Ann Pharmacother; 2005 Apr; 39(4):773. PubMed ID: 15741414
    [No Abstract]   [Full Text] [Related]  

  • 24. Choline therapy in Huntington chorea.
    Aquilonius SM; Eckernas SA
    Neurology; 1977 Sep; 27(9):887-9. PubMed ID: 142929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Letter: Plasma concentration of free choline in patients with Huntington's chorea on high doses of choline chloride.
    Aquilonius SM; Eckernäs SA
    N Engl J Med; 1975 Nov; 293(21):1105-6. PubMed ID: 126381
    [No Abstract]   [Full Text] [Related]  

  • 26. Oral choline in tardive dyskinesia.
    Ray R; Ramakrishnan N; Rao BS
    Indian J Med Res; 1982 Oct; 76():628-31. PubMed ID: 7152571
    [No Abstract]   [Full Text] [Related]  

  • 27. Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease.
    Lastres-Becker I; Hansen HH; Berrendero F; De Miguel R; Pérez-Rosado A; Manzanares J; Ramos JA; Fernández-Ruiz J
    Synapse; 2002 Apr; 44(1):23-35. PubMed ID: 11842443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The use of choline in the treatment of Huntington's chorea].
    Sancesario G; Panichelli C; Bianco F; Caporali M; Piccinin GL; Stanzione P; Morocutti C
    Clin Ter; 1981 Feb; 96(4):393-6. PubMed ID: 6452245
    [No Abstract]   [Full Text] [Related]  

  • 29. Regulatory peptides in animal paradigms of neuropsychiatric illness.
    Diamond BI; Borison RL
    Adv Biochem Psychopharmacol; 1982; 33():541-8. PubMed ID: 6214928
    [No Abstract]   [Full Text] [Related]  

  • 30. Lecithin can suppress tardive dyskinesia.
    Growdon JH; Gelenberg AJ; Doller J; Hirsch MJ; Wurtman RJ
    N Engl J Med; 1978 May; 298(18):1029-30. PubMed ID: 642995
    [No Abstract]   [Full Text] [Related]  

  • 31. Clozapine in tardive dyskinesia: observations from human and animal model studies.
    Tamminga CA; Thaker GK; Moran M; Kakigi T; Gao XM
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():102-6. PubMed ID: 7961550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Huntington's disease: clinical and chemical effects of choline administration.
    Growdon JH; Cohen EL; Wurtman RJ
    Ann Neurol; 1977 May; 1(5):418-22. PubMed ID: 152596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lecithin in neurologic disorders.
    Barbeau A
    N Engl J Med; 1978 Jul; 299(4):200-1. PubMed ID: 149251
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of dyskinesias with tiapride (author's transl)].
    Kocher R; Hobi V
    Sem Hop; 1980 Dec 18-25; 56(47-68):2033-4. PubMed ID: 6109379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-dose pyridoxine in tardive dyskinesia.
    DeVeaugh-Geiss J; Manion L
    J Clin Psychiatry; 1978 Jun; 39(6):573-5. PubMed ID: 350860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Therapeutical approach to involuntary movements (author's transl)].
    Allain H; Sabouraud O
    Sem Hop; 1979 Feb 8-15; 55(5-6):262-4. PubMed ID: 219537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kainic acid animal model predicts therapeutic agents in Huntington's chorea.
    Borison RL; Diamond BI
    Trans Am Neurol Assoc; 1979; 104():67-9. PubMed ID: 162258
    [No Abstract]   [Full Text] [Related]  

  • 38. Emerging drug therapies in Huntington's disease.
    Mason SL; Barker RA
    Expert Opin Emerg Drugs; 2009 Jun; 14(2):273-97. PubMed ID: 19453283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clozapine therapy for Parkinson's disease and other movement disorders.
    Pfeiffer C; Wagner ML
    Am J Hosp Pharm; 1994 Dec; 51(24):3047-53. PubMed ID: 7856623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dementia in the aged.
    Spar JE
    Psychiatr Clin North Am; 1982 Apr; 5(1):67-86. PubMed ID: 6212916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.